✦ LIBER ✦

Oxaliplatin plus irinotecan promising as first-line treatment for advanced colorectal cancer

Book ID: 120864743
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 151 KB
Volume: 1327
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213270-00034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan plus Oxaliplatin: a Promising

Irinotecan plus Oxaliplatin: a Promising Combination for Advanced Colorectal Cancer

✍ Ernesto Wasserman; William Sutherland; Esteban Cvitkovic 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 100 KB

Irinotecan plus oxaliplatin a promising

Irinotecan plus oxaliplatin a promising first-line gastric cancer therapy

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Phase III trial of irinotecan plus infus

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

✍ Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 391 KB

668 PUBLICATION Concurrent irinotecan, o

668 PUBLICATION Concurrent irinotecan, oxaliplatin and uft/lv triple therapy as first-line treatment for advanced colorectal cancer (ACRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Phase II randomised trial of raltitrexed

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

✍ Feliu, J; Castañón, C; Salud, A; Mel, J R; Escudero, P; Pelegrín, A; López-Gómez 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF